DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹10,152 Cr | ₹9,750 Cr | ₹9,610 Cr | ₹6,791 Cr | ₹5,574 Cr |
What is the latest Total Current Assets ratio of DIVIS LABORATORIES ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹10,152 Cr |
Mar2023 | ₹9,750 Cr |
Mar2022 | ₹9,610 Cr |
Mar2021 | ₹6,791 Cr |
Mar2020 | ₹5,574 Cr |
How is Total Current Assets of DIVIS LABORATORIES Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹10,152 Cr | 4.12 | |
Mar2023 | ₹9,750 Cr | 1.45 | |
Mar2022 | ₹9,610 Cr | 41.52 | |
Mar2021 | ₹6,791 Cr | 21.84 | |
Mar2020 | ₹5,574 Cr | - |
Compare Total Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹177,593.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.7% |
7.4% |
48.1% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses